Sanofi Aventis: FDA Grants BSI-201 Fast Track Designation
9 hours 0 minutes ago PARIS (Dow Jones)--French pharmaceuticals giant Sanofi-Aventis SA (SNY) said Friday its bipar Sciences unit's BSI-201 metastatic triple-negative breast ...
Sanofi-Aventis Signs Agreement With Alopexx
Dec 10, 2009 04:34:53 PARIS (Dow Jones)--French drugs company Sanofi-Aventis (SNY) said Thursday it has signed an agreement worth as much as $375 million with US biotechnology ...
Generex Inks Deal With Sanofi-Aventis for Insulin Supply
Dec 09, 2009 09:36:14 The Company's regulatory team will commence the process of updating any and all current submissions to include sanofi-aventis' insulin crystal which will be ...
Sanofi-Aventis in research pact with CalTech
Dec 09, 2009 11:20:31 NEW YORK — French drugmaker Sanofi-Aventis said Wednesday it is entering a research collaboration with the California Institute of Technology in Pasadena, ...